Skip to Main Content

Author Details

Shuiying Hu
The Ohio State University
2005
78
33
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38071551Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice.Drug Metab Dispos2024
37347545Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy.JCI Insight2023
32761456Solute Carrier Transportome in Chemotherapy-Induced Adverse Drug Reactions.Rev Physiol Biochem Pharmacol2022
35383108Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.Mol Pharmacol2022
35546260Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4.Clin Pharmacol Ther2022
35390174Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium.Clin Pharmacol Ther2022
36506732Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.Cancer Res Commun2022
36145680A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities.Pharmaceutics2022
35955741MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia.Int J Mol Sci2022
36296409Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B.Molecules2022
36054985Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS method.J Chromatogr B Analyt Technol Biomed Life Sci2022
35983889The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature.Expert Opin Drug Metab Toxicol2022
34237188Contribution of membrane transporters to chemotherapy-induced cardiotoxicity.Basic Clin Pharmacol Toxicol2022
32905646DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia.Clin Transl Sci2021
33495337Targeting OCT3 attenuates doxorubicin-induced cardiac injury.Proc Natl Acad Sci U S A2021
33684722Rapid quantification of vincristine in mouse plasma using ESI-LC-MS/MS: Application to pharmacokinetic studies.J Chromatogr B Analyt Technol Biomed Life Sci2021
33790797Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1.Front Pharmacol2021
33673136Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.Cancers (Basel)2021
33664059Regulation of OATP1B1 Function by Tyrosine Kinase-mediated Phosphorylation.Clin Cancer Res2021
34959286<i>In Vitro</i> and <i>In Vivo</i> Inhibition of MATE1 by Tyrosine Kinase Inhibitors.Pharmaceutics2021
34576971Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation.Molecules2021
34205780Imaging-Based Characterization of a <i>Slco2b1<sup>(-/-)</sup></i> Mouse Model Using [<sup>11</sup>C]Erlotinib and [<sup>99m</sup>Tc]Mebrofenin as Probe Substrates.Pharmaceutics2021
33142018Role for Drug Transporters in Chemotherapy-Induced Peripheral Neuropathy.Clin Transl Sci2021
31350763Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1.Clin Pharmacol Ther2020
33553600Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy.Mol Cell Oncol2020
31924044Corrigendum to "Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy" [Mater Sci Eng C 102 (2019) 113-123].Mater Sci Eng C Mater Biol Appl2020
32114507Role of Oatp2b1 in Drug Absorption and Drug-Drug Interactions.Drug Metab Dispos2020
32276560Role of <i>SLC</i> transporters in toxicity induced by anticancer drugs.Expert Opin Drug Metab Toxicol2020
32484793Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.J Clin Invest2020
31055183Development and validation of a UPLC-MS/MS analytical method for dofetilide in mouse plasma and urine, and its application to pharmacokinetic study.J Pharm Biomed Anal2019
31671477Predicting Paclitaxel Disposition in Humans With Whole-Body Physiologically-Based Pharmacokinetic Modeling.CPT Pharmacometrics Syst Pharmacol2019
31832201Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.Pharmacol Res Perspect2019
30955241Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in Mice.Clin Transl Sci2019
31123053Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.Clin Cancer Res2019
31146981Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy.Mater Sci Eng C Mater Biol Appl2019
29337310OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.J Clin Invest2018
30028006Strategies to Reduce Solute Carrier-Mediated Toxicity.Clin Pharmacol Ther2018
29991332Drug transporters and anthracycline-induced cardiotoxicity.Pharmacogenomics2018
31106235Murine Pharmacokinetic Studies.Bio Protoc2018
29783173Development and validation of an analytical method for regorafenib and its metabolites in mouse plasma.J Chromatogr B Analyt Technol Biomed Life Sci2018
28689374Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.Clin Transl Sci2017
28371445Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide.Clin Transl Sci2017
28209616OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.Cancer Res2017
28704838Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.Br J Cancer2017
26842729ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression.Clin Transl Sci2016
26677977Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death.Cancer Res2016
26663398Inherited variation in OATP1B1 is associated with treatment outcome in acute myeloid leukemia.Clin Pharmacol Ther2016
27125973Evaluation of artemisinins for the treatment of acute myeloid leukemia.Cancer Chemother Pharmacol2016
26979622A phosphotyrosine switch regulates organic cation transporters.Nat Commun2016
25952649Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b.Cancer Res2015
  • 1 - 50 of 78

Recommended Authors

Xun Bao
Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute
Career Start Year 2014
Number of shared co-authors 1
Eugene C Chen
Department of Drug Metabolism and Pharmacokinetics, Inc.
Career Start Year 2010
Number of shared co-authors 4
Lawrence Lin
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 2
Kunal S Taskar
Drug Metabolism and Pharmacokinetics
Career Start Year 2009
Number of shared co-authors 0
Arik A Zur
Schools of Pharmacy and Medicine, University of California san francisco
Career Start Year 2009
Number of shared co-authors 4
Rajendar K Mittapalli
Pfizer Inc.
Career Start Year 2008
Number of shared co-authors 0
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 0
John F Reilly
Goldfinch Bio Inc.
Career Start Year 2007
Number of shared co-authors 0
Natalia Khuri
Stanford University
Career Start Year 2007
Number of shared co-authors 3
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 4
Kari M Morrissey
Amunix Pharmaceuticals
Career Start Year 2006
Number of shared co-authors 3
P??r Matsson
University of Gothenburg
Career Start Year 2005
Number of shared co-authors 3
Leslie W Chinn
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 2
Neeltje Steeghs
Netherlands Cancer Institute-Antoni Van Leeuwenhoek
Career Start Year 2003
Number of shared co-authors 3
Sook Wah Yee
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 6
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year 2000
Number of shared co-authors 2
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year 1998
Number of shared co-authors 0
Salvador Fudio
Clinical Development
Career Start Year 1998
Number of shared co-authors 1
Sunil Sharma
Brody School of Medicine, East Carolina University
Career Start Year 1997
Number of shared co-authors 4
David de Graaf
Syntimmune Inc.
Career Start Year 1995
Number of shared co-authors 0
Cynthia Sung
Health Services and Systems Research, Duke-NUS Medical School
Career Start Year 1990
Number of shared co-authors 0
Francois Pognan
Novartis
Career Start Year 1988
Number of shared co-authors 0
Chiara Riganti
University of Turin
Career Start Year 1985
Number of shared co-authors 0
Mark J Ratain
University of Chicago
Career Start Year 1985
Number of shared co-authors 7
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Career Start Year 1979
Number of shared co-authors 12
Kathleen M Giacomini
University of California San Francisco
Career Start Year 1978
Number of shared co-authors 8
Anne Monks
Institute of Biomedical Engineering (IBME), University of Oxford
Career Start Year 1976
Number of shared co-authors 0
Paul Workman
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 1
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 4
James H Doroshow
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 2

Collaborators

Alex Sparreboom
Ohio State University
Co-authored papers 56
Sharyn D Baker
Ohio State University
Co-authored papers 37
Alice A Gibson
The Ohio State University
Co-authored papers 29
Lie Li
Sino-French Hoffmann Institute, Guangzhou Medical University
Co-authored papers 12
Jason A Sprowl
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Co-authored papers 12
Guoqing Du
Second Affiliated Hospital of Harbin Medical University
Co-authored papers 6
Navjotsingh Pabla
The Ohio State University
Co-authored papers 5
Guido Cavaletti
NeuroMI (Milan Center for Neuroscience)
Co-authored papers 5
Aksana Vasilyeva
St Jude Children's Research Hospital
Co-authored papers 5
Taosheng Chen
St. Jude Children's Research Hospital
Co-authored papers 5
Anne T Nies
and University of Tuebingen, University of Tuebingen
Co-authored papers 5
Su Sien Ong
St. Jude Children's Research Hospital
Co-authored papers 4
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 4
Stanley Pounds
St. Jude Children's Research Hospital.
Co-authored papers 4
Giuliano Ciarimboli
University Hospital Munster
Co-authored papers 3
Eberhard Schlatter
University Hospital Muenster
Co-authored papers 3
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 2
Rong Fan
Institute of Pathogens and Vectors, Dali University
Co-authored papers 2
Charles L Loprinzi
Mayo Clinic
Co-authored papers 2
William E Evans
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 2
Daelynn R Buelow
The Ohio State University
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Shashank Bharill
University of California berkeley
Co-authored papers 1
Robert B Diasio
Mayo Clinic
Co-authored papers 1
Rachel A Ness
4Department of Pharmacy, Memphis Veterans Affairs Medical Center
Co-authored papers 1
Anang A Shelat
St. Jude Children's Research Hospital
Co-authored papers 1
Ehud Y Isacoff
University of California berkeley
Co-authored papers 1
Deanna L Kroetz
University of California San Francisco
Co-authored papers 1
Jerold E Rehg
St. Jude Children's Research Hospital
Co-authored papers 1
Joseph A Califano
University of California
Co-authored papers 1
Release 1.2